Skip to main content

Dementia: Clinical Trials

Question for Department of Health and Social Care

UIN 7624, tabled on 24 January 2020

To ask the Secretary of State for Health and Social Care, if he will make it his Department's policy to increase the level of funding for the early stage of clinical trials of dementia medicines.

Answered on

29 January 2020

The Government remains strongly committed to supporting research into dementia and the United Kingdom research community is playing a significant role in the global effort to find a cure or a major disease-modifying treatment by 2025.

The Government’s 2020 Challenge contained the commitment to spend £300 million on dementia research over the five years to March 2020. This commitment was delivered a year early with £341 million spent on dementia research over the four years to 31 March 2019. We are currently working on ways to significantly boost further research on dementia at all stages of the translation pathway, including on early-phase clinical trials.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.